ENG rs1085307431: Understanding This Rare Genetic Variant

What each genotype means

What is the rs1085307431 Variant?

The rs1085307431 variant is a specific change in the DNA sequence of the ENG gene. In genomics, an rsID (reference SNP cluster ID) acts as a unique identifier for a specific location in the human genome. This particular variant is categorized as rare, meaning it is found in a very small percentage of the general population. Genetic variants like this one are identified through large-scale sequencing projects that compare DNA across diverse groups of people. Because this variant is rare, it is not typically included in standard, broad-spectrum ancestry or wellness genetic tests. Researchers study such variants to understand how specific changes in the genetic code might influence biological processes or contribute to the development of certain health conditions. It is important to remember that the presence of a rare variant does not automatically imply a health outcome, as many rare variants are benign and have no observable effect on human health.

The Role of the ENG Gene

The ENG gene provides instructions for producing a protein called endoglin. Endoglin is a transmembrane protein primarily found on the surface of endothelial cells, which are the cells that line the interior of blood vessels. This protein plays a critical role in the transforming growth factor-beta (TGF-beta) signaling pathway, which is essential for regulating cell growth, differentiation, and the maintenance of vascular integrity. By interacting with various growth factors, endoglin helps control the development and stability of the circulatory system. When the ENG gene is altered, it can lead to a reduction in the amount of functional endoglin protein available. A shortage of this protein can disrupt the normal signaling required for healthy blood vessel formation, potentially leading to the vascular abnormalities characteristic of hereditary hemorrhagic telangiectasia (HHT). Understanding this gene is vital for researchers investigating how vascular health is maintained at the molecular level.

Research Associations and Evidence

The ENG gene is well-established in scientific literature as a primary cause of hereditary hemorrhagic telangiectasia type 1 (HHT1). HHT is an autosomal dominant disorder, meaning that a single altered copy of the gene is sufficient to increase the risk of developing the condition. The evidence linking specific pathogenic variants in ENG to HHT is considered strong, and the gene is included in clinical panels used to diagnose the condition. However, the evidence strength for any single specific variant, such as rs1085307431, can vary. While some variants are clearly pathogenic, others may be classified as variants of uncertain significance (VUS) until more clinical data is gathered. Current research emphasizes that HHT is often underdiagnosed due to its variable clinical presentation, which can range from mild nosebleeds to more severe internal vascular malformations. Clinical diagnosis is typically based on established criteria, such as the Curacao criteria, rather than genetic testing alone.

Population Frequency and Interpretation

The rs1085307431 variant is documented as rare across global populations. In genomic databases like gnomAD, rare variants are often found at extremely low frequencies, sometimes appearing in only a handful of individuals out of hundreds of thousands. Because of this rarity, it is difficult to establish precise frequency statistics for specific ancestral groups. When interpreting genetic information, it is essential to distinguish between a variant being 'rare' and a variant being 'causal.' Many rare variants are neutral and do not cause disease. If you have received information about this variant from a genetic report, it is important to discuss the findings with a qualified healthcare professional or a genetic counselor. They can provide context based on your personal and family medical history. Genetic information is complex, and a professional can help you understand whether a specific variant is relevant to your health or if it is simply a normal part of human genetic variation.

What You Can Do With This Information

If you are concerned about hereditary hemorrhagic telangiectasia or have a family history of vascular issues, the most important step is to consult with a medical professional. Genetic testing for HHT is typically performed in a clinical setting where results can be interpreted in the context of a physical examination and clinical symptoms. You cannot use a raw data file or a single SNP report to diagnose yourself or family members. If a clinician orders genetic testing, they will provide guidance on what the results mean for your health and whether any follow-up screenings are necessary. Avoid making medical decisions based on online reports or raw genetic data. Always rely on the expertise of doctors, specialists, or genetic counselors who can integrate your genetic information with your overall health profile to provide accurate, actionable medical advice.

Frequently asked questions

Sources & further reading

Related variants in ENG